Titre : Érythropoïèse

Érythropoïèse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Visual Acuity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Érythropoïèse : Questions médicales les plus fréquentes", "headline": "Érythropoïèse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Érythropoïèse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-03", "dateModified": "2025-03-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Érythropoïèse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hématopoïèse", "url": "https://questionsmedicales.fr/mesh/D006410", "about": { "@type": "MedicalCondition", "name": "Hématopoïèse", "code": { "@type": "MedicalCode", "code": "D006410", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.188.343" } } }, "about": { "@type": "MedicalCondition", "name": "Érythropoïèse", "alternateName": "Erythropoiesis", "code": { "@type": "MedicalCode", "code": "D004920", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Christopher D Hillyer", "url": "https://questionsmedicales.fr/author/Christopher%20D%20Hillyer", "affiliation": { "@type": "Organization", "name": "New York Blood Center, New York, New York, USA." } }, { "@type": "Person", "name": "Narla Mohandas", "url": "https://questionsmedicales.fr/author/Narla%20Mohandas", "affiliation": { "@type": "Organization", "name": "New York Blood Center, New York, New York, USA." } }, { "@type": "Person", "name": "Lihong Shi", "url": "https://questionsmedicales.fr/author/Lihong%20Shi", "affiliation": { "@type": "Organization", "name": "Institute of Hematology & Blood Diseases Hospital, Chinese academy of medical sciences, Tianjin, China." } }, { "@type": "Person", "name": "Yukio Nakamura", "url": "https://questionsmedicales.fr/author/Yukio%20Nakamura", "affiliation": { "@type": "Organization", "name": "Cell Engineering Division, RIKEN BioResource Research Center, Ibaraki 305-0074, Japan." } }, { "@type": "Person", "name": "Xiuli An", "url": "https://questionsmedicales.fr/author/Xiuli%20An", "affiliation": { "@type": "Organization", "name": "Red Cell Physiology Laboratory, New York Blood Center, New York, NY 10065, USA; Laboratory of Membrane Biology, Zhengzhou University, Zhengzhou, Henan 450001, China; College of Life Science, Zhengzhou University, Zhengzhou, Henan 450001, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Mental health and visual acuity in patients with age-related macular degeneration.", "datePublished": "2022-10-02", "url": "https://questionsmedicales.fr/article/36183081", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12886-022-02602-9" } }, { "@type": "ScholarlyArticle", "name": "Factors associated with visual acuity improvement with a binocular digital therapeutic for amblyopia.", "datePublished": "2023-08-21", "url": "https://questionsmedicales.fr/article/37611818", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaapos.2023.06.007" } }, { "@type": "ScholarlyArticle", "name": "Prevalence of Impairment of Visual Acuity and Severity of Retinopathy in Patients with Diabetes Mellitus.", "datePublished": "2022-08-08", "url": "https://questionsmedicales.fr/article/35940177", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1752-0024" } }, { "@type": "ScholarlyArticle", "name": "Relationship between dynamic visual acuity and multiple object tracking performance.", "datePublished": "2022-06-06", "url": "https://questionsmedicales.fr/article/35668637", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/03010066221104281" } }, { "@type": "ScholarlyArticle", "name": "Diurnal Variation of Visual Acuity and Refraction in Fuchs Endothelial Corneal Dystrophy.", "datePublished": "2023-05-08", "url": "https://questionsmedicales.fr/article/37157119", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/ICO.0000000000003291" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes physiologiques respiratoires et circulatoires", "item": "https://questionsmedicales.fr/mesh/D002943" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes physiogiques du sang", "item": "https://questionsmedicales.fr/mesh/D001790" }, { "@type": "ListItem", "position": 4, "name": "Hématopoïèse", "item": "https://questionsmedicales.fr/mesh/D006410" }, { "@type": "ListItem", "position": 5, "name": "Érythropoïèse", "item": "https://questionsmedicales.fr/mesh/D004920" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Érythropoïèse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Érythropoïèse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Érythropoïèse", "description": "Comment diagnostiquer une anémie par érythropoïèse insuffisante ?\nQuels tests sont utilisés pour évaluer l'érythropoïèse ?\nQuels signes indiquent une érythropoïèse altérée ?\nComment évaluer la moelle osseuse pour l'érythropoïèse ?\nQuel rôle joue l'érythropoïétine dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D004920?mesh_terms=Visual+Acuity&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Érythropoïèse", "description": "Quels sont les symptômes d'une érythropoïèse déficiente ?\nComment l'anémie affecte-t-elle l'érythropoïèse ?\nQuels signes cliniques sont associés à l'érythropoïèse ?\nL'érythropoïèse affecte-t-elle la circulation sanguine ?\nQuels symptômes peuvent indiquer une surproduction de globules rouges ?", "url": "https://questionsmedicales.fr/mesh/D004920?mesh_terms=Visual+Acuity&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Érythropoïèse", "description": "Comment prévenir l'anémie liée à l'érythropoïèse ?\nQuels conseils nutritionnels pour soutenir l'érythropoïèse ?\nComment éviter les carences nutritionnelles ?\nQuels sont les risques d'une érythropoïèse excessive ?\nComment surveiller l'érythropoïèse chez les patients à risque ?", "url": "https://questionsmedicales.fr/mesh/D004920?mesh_terms=Visual+Acuity&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Érythropoïèse", "description": "Quels traitements sont disponibles pour l'anémie ?\nComment l'érythropoïétine est-elle utilisée en thérapie ?\nQuels médicaments peuvent affecter l'érythropoïèse ?\nQuelles sont les options pour l'érythropoïèse excessive ?\nComment traiter une carence en vitamine B12 liée à l'érythropoïèse ?", "url": "https://questionsmedicales.fr/mesh/D004920?mesh_terms=Visual+Acuity&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Érythropoïèse", "description": "Quelles complications peuvent survenir avec une érythropoïèse altérée ?\nComment l'érythropoïèse excessive peut-elle affecter la santé ?\nQuels risques sont associés à une érythropoïèse insuffisante ?\nComment l'érythropoïèse affecte-t-elle le système immunitaire ?\nQuelles sont les complications à long terme d'une érythropoïèse déficiente ?", "url": "https://questionsmedicales.fr/mesh/D004920?mesh_terms=Visual+Acuity&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Érythropoïèse", "description": "Quels facteurs augmentent le risque d'anémie ?\nComment les maladies rénales affectent-elles l'érythropoïèse ?\nQuel rôle joue l'âge dans l'érythropoïèse ?\nQuels sont les risques liés à la grossesse pour l'érythropoïèse ?\nComment le tabagisme influence-t-il l'érythropoïèse ?", "url": "https://questionsmedicales.fr/mesh/D004920?mesh_terms=Visual+Acuity&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anémie par érythropoïèse insuffisante ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un bilan sanguin révèle une faible concentration de globules rouges et d'hémoglobine." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'érythropoïèse ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la numération globulaire complète et les niveaux d'érythropoïétine." } }, { "@type": "Question", "name": "Quels signes indiquent une érythropoïèse altérée ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent fatigue, pâleur et essoufflement lors d'efforts physiques." } }, { "@type": "Question", "name": "Comment évaluer la moelle osseuse pour l'érythropoïèse ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie de moelle osseuse permet d'analyser la production de globules rouges." } }, { "@type": "Question", "name": "Quel rôle joue l'érythropoïétine dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'érythropoïétine stimule la production de globules rouges, son dosage aide au diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une érythropoïèse déficiente ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, faiblesse, palpitations et essoufflement." } }, { "@type": "Question", "name": "Comment l'anémie affecte-t-elle l'érythropoïèse ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'anémie peut résulter d'une érythropoïèse insuffisante, entraînant une diminution des globules rouges." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés à l'érythropoïèse ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la pâleur de la peau et des muqueuses peuvent être observés." } }, { "@type": "Question", "name": "L'érythropoïèse affecte-t-elle la circulation sanguine ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une érythropoïèse altérée peut entraîner une mauvaise oxygénation des tissus." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une surproduction de globules rouges ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des maux de tête, des vertiges et une hypertension peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir l'anémie liée à l'érythropoïèse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en fer et en vitamines est essentielle pour prévenir l'anémie." } }, { "@type": "Question", "name": "Quels conseils nutritionnels pour soutenir l'érythropoïèse ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Consommer des aliments riches en fer, vitamine B12 et acide folique favorise l'érythropoïèse." } }, { "@type": "Question", "name": "Comment éviter les carences nutritionnelles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation variée et des contrôles réguliers des niveaux de nutriments aident à prévenir les carences." } }, { "@type": "Question", "name": "Quels sont les risques d'une érythropoïèse excessive ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'érythropoïèse excessive peut entraîner des complications comme des thromboses et des AVC." } }, { "@type": "Question", "name": "Comment surveiller l'érythropoïèse chez les patients à risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des bilans sanguins réguliers permettent de surveiller l'érythropoïèse chez les patients à risque." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'anémie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des suppléments de fer, des transfusions sanguines et des érythropoïétines." } }, { "@type": "Question", "name": "Comment l'érythropoïétine est-elle utilisée en thérapie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'érythropoïétine est administrée pour stimuler la production de globules rouges chez les patients anémiques." } }, { "@type": "Question", "name": "Quels médicaments peuvent affecter l'érythropoïèse ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments comme les anti-inflammatoires peuvent inhiber l'érythropoïèse." } }, { "@type": "Question", "name": "Quelles sont les options pour l'érythropoïèse excessive ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements comme la phlébotomie peuvent être utilisés pour réduire le nombre de globules rouges." } }, { "@type": "Question", "name": "Comment traiter une carence en vitamine B12 liée à l'érythropoïèse ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments de vitamine B12 sont prescrits pour corriger la carence et améliorer l'érythropoïèse." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une érythropoïèse altérée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent l'anémie, la fatigue chronique et des problèmes cardiaques." } }, { "@type": "Question", "name": "Comment l'érythropoïèse excessive peut-elle affecter la santé ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des complications comme des caillots sanguins et des problèmes cardiovasculaires." } }, { "@type": "Question", "name": "Quels risques sont associés à une érythropoïèse insuffisante ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent une hypoxie tissulaire, des troubles cognitifs et une diminution de la qualité de vie." } }, { "@type": "Question", "name": "Comment l'érythropoïèse affecte-t-elle le système immunitaire ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une érythropoïèse altérée peut affaiblir le système immunitaire, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Quelles sont les complications à long terme d'une érythropoïèse déficiente ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications à long terme incluent des maladies cardiaques et des troubles métaboliques." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'anémie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent une mauvaise alimentation, des maladies chroniques et des pertes sanguines." } }, { "@type": "Question", "name": "Comment les maladies rénales affectent-elles l'érythropoïèse ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les maladies rénales peuvent réduire la production d'érythropoïétine, entraînant une érythropoïèse insuffisante." } }, { "@type": "Question", "name": "Quel rôle joue l'âge dans l'érythropoïèse ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Avec l'âge, la production de globules rouges peut diminuer, augmentant le risque d'anémie." } }, { "@type": "Question", "name": "Quels sont les risques liés à la grossesse pour l'érythropoïèse ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "La grossesse peut entraîner une anémie due à une demande accrue en fer et en nutriments." } }, { "@type": "Question", "name": "Comment le tabagisme influence-t-il l'érythropoïèse ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme peut augmenter le nombre de globules rouges, mais aussi causer des complications respiratoires." } } ] } ] }

Sources (10000 au total)

Mental health and visual acuity in patients with age-related macular degeneration.

Visual acuity (VA) loss has been associated with depression in patients with age-related macular degeneration (AMD). However, previous studies did not incorporate subgroups of AMD when correlating VA ... AMD patients classified by multi-modal imaging were recruited into an AMD registry. Habitual VA was obtained by ophthalmic technicians using the Snellen VA at distance. At enrollment, patients complet... Eight hundred seventy-five patients were included in the study. Patients with bilateral geographic atrophy (GA) or bilateral GA and neovascular (NV) AMD scored lowest on the mental health subscales wi... There is a significant association between mental health questionnaire scores and AMD classification, as well as VA in both the better and worse-seeing eyes in patients with AMD. It is important for c...

Prevalence of Impairment of Visual Acuity and Severity of Retinopathy in Patients with Diabetes Mellitus.

No information exists on the frequency of visual impairment in people with diabetes mellitus (DM) in Germany. In this study, the prevalence of vision impairment in those individuals was investigated.... We retrospectively analyzed a cohort of 295 people (14221 consultations) at a university outpatient clinic with any type of DM and an available ETDRS-Score and visual acuity. The primary outcome was t... The prevalence of visual impairment in participants with DM was 11.2%; among these individuals, 81.8% had no or non-proliferative retinopathy. In the DM2 subgroup, 81.5% (n=22) of the visually impaire... The prevalence of impaired vision in people with diabetes in our cohort was 11.2%,<20% of visual impairment in people with diabetes is caused by diabetic retinopathy, and 69.7% of participants with vi...

Diurnal Variation of Visual Acuity and Refraction in Fuchs Endothelial Corneal Dystrophy.

Patients with advanced Fuchs endothelial corneal dystrophy frequently report poor vision in the morning, which improves as the day progresses. This study quantified the amount of variation in near and... This was a prospective cohort study. Best-corrected distance visual acuity and near visual acuity were tested in participants with clinically advanced Fuchs dystrophy and in controls with healthy corn... In Fuchs dystrophy, the mean distance visual acuity was worse by -3 letters (95% confidence interval, -4 to -1) directly after eye opening in the morning compared with late afternoon. No such differen... Distance and near visual acuity and refraction changes over the course of the day in patients with advanced Fuchs dystrophy. Although small changes in refraction may not usually require a second set o...

Pupil size effect on binocular summation for visual acuity and light disturbance.

Smaller pupil size under binocular conditions could justify partially the improvement of visual performance when compared to monocular conditions. The purpose of this study was to assess the binocular... Fifteen young subjects were recruited in this crossover study. Light disturbance index (LDI) was evaluated with the light disturbance analyzer and low (LCDVA) and high (HCDVA) contrast visual acuity w... Our results showed poorer visual performance in monocular than the binocular condition. An increasing deterioration was observed with the level of spherical defocus. Positive binocular summation for v... Binocular summation was observed under different conditions of spherical and cylindrical optical degradation of the image quality when the pupil size was fully controlled. This suggests that a neural ...

Impact of induced pseudomyopia and refractive fluctuations of accommodative spasm on visual acuity.

High-contrast visual acuity is disproportionately poor in patients with accommodative spasm subtype of near reflex (SNR-A), relative to uncorrected refractive errors of equivalent magnitude. This exag... To determine how combinations of pseudomyopic refraction and its temporal variations in SNR-A impact high-contrast visual acuity by inducing these patterns in healthy cyclopleged adults, relative to t... Refractive profiles of 15 patients with SNR-A were obtained from a previous study, averaged, and induced before the right eye of 14 cyclopleged adults (mean ±1 SD age: 22.7 ± 2.6 yrs) by feeding the p... The induced refractive fluctuations ranged from -0.80 to -1.75D, around a mean pseudomyopia of -1.20D. Visual acuity deterioration was maximum for the combination of pseudomyopia and temporal fluctuat... Combination of induced pseudomyopia and temporal fluctuations in refraction produces an additive loss of visual acuity and task precision, relative to baseline and each factor considered separately....

Cataract surgery in neovascular AMD: impact on visual acuity and disease activity.

Cataract and neovascular age-related macular degeneration (nAMD) often co-exist and both contribute to impaired vision. It has been debated whether cataract surgery can increase nAMD activity. The pur... Data was obtained from the Swedish Macular Register, the Swedish National Cataract Register, optical coherence tomography (OCT) images and patient charts. All eyes were treated at the Department of Op... In total, 156 patients (168 eyes) were included. The mean age at cataract surgery was 82 (standard deviation, SD 6) years. Both distance and near visual acuity improved after surgery. Distance visual ... Cataract surgery improved visual acuity in patients with on-going treatment for nAMD and did not affect anti-VEGF treatment intensity. Macular morphology remained unchanged. The slight increase in int...